People channel feed

Gilead lands in North Car­oli­na with a plan to hire 300 for new cen­ter

4 years ago

Flush with cash, Rakuten bil­lion­aire Mick­ey Mik­i­tani looks to take his pho­toim­munother­a­py plat­form glob­al

4 years ago
Financing

Chi­nese re­searcher — and for­mer 'fugi­tive' — re­turns home af­ter DOJ moves to drop a spate of cas­es

4 years ago
China

Bob Nelsen's ARCH adds FDA, biode­fense ex­per­tise with ap­point­ment of Lu­ciana Bo­rio

4 years ago

Ex-Mer­ck chief Ken Fra­zier takes a lead­ing role in a $600M 'Health As­sur­ance' ven­ture fund

4 years ago

A top Mor­gan Stan­ley sell-side an­a­lyst makes the jump from out­side play­er to biotech C-suite in­sid­er

4 years ago

Sean Park­er-backed cell ther­a­py start­up Ar­se­nal­Bio plucks Mer­ck VP as new CSO

4 years ago
Cell/Gene Tx

Gilead still has­n't made up its mind about Ar­cus' drugs, but there's a top ex­ec at the biotech it def­i­nite­ly wants

4 years ago

Polyphor ax­es staff as cash and op­tions dwin­dle

4 years ago

Tessera Ther­a­peu­tics taps for­mer BeiGene CFO Howard Liang to join race to CRISPR 3.0

4 years ago

Ovid shuf­fles C-suite, lays off staff in wake of PhI­II An­gel­man syn­drome fail

4 years ago
R&D
Pharma

A uni­corn built on lies? Founders of Sanofi part­ner may face 20 years in prison for al­leged­ly prof­it­ing from stolen Genen­tech trade se­crets

4 years ago

Ax­el Hoos, the keep­er of the on­col­o­gy flame at Glax­o­SmithK­line, steps away for his next chal­lenge at tiny Scor­pi­on

4 years ago

Scoop: Am­gen re­cruits renowned can­cer drug in­ves­ti­ga­tor Jean-Charles So­ria to lead a grow­ing pipeline play

4 years ago

Mod­er­na hires a chief brand of­fi­cer to guide vac­cine cam­paigns through 'time of rapid growth'

4 years ago

At biotech's small­est com­pa­nies, fe­male ex­ec­u­tives make up on­ly a frac­tion of C-suite lead­ers — re­port

4 years ago

Or­p­hazyme plans to lay off most of its staff fol­low­ing a string of fail­ures for lead 'pipeline-in-a-pro­duc­t'

4 years ago

As­traZeneca CEO Pas­cal So­ri­ot taps vet­er­an can­cer re­searcher Su­san Gal­braith for top on­col­o­gy post

4 years ago

Q&A: When the pan­dem­ic struck, Catal­en­t's CCO had just joined the team

4 years ago
Manufacturing

Out­spo­ken drug pric­ing re­searcher Pe­ter Bach takes CMO gig at liq­uid biop­sy start­up

4 years ago

Gala­pa­gos CSO hits the ex­it as the biotech looks to pick up the pieces af­ter FDA's fil­go­tinib re­jec­tion

4 years ago

Al­lo­gene, Over­land woo an ex­pe­ri­enced hand from WuXi to steer their al­lo­gene­ic CAR-T JV

4 years ago
China
Cell/Gene Tx

Ac­tivist in­vestor El­liott in talks with oth­er Glax­o­SmithK­line in­vestors about re­plac­ing Em­ma Walm­s­ley, spin­ning off vac­cine busi­ness — re­port

4 years ago
Pharma

Biotech founder placed on leave as $400M Alzheimer's start­up idea comes un­der scruti­ny

4 years ago
R&D
First page Previous page 55565758596061 Next page Last page
A service from the Financial Times